MAPT and Alzheimer disease: Despite the limitations, that no amyloid-ß PET was available, and the lack of longitudinal biomarker measurements on CSF or PET, this case provides in vivo evidence to support the hypothesis that an association exists between neuronal activity and tau pathology in early AD pathogenesis [21, 22], however no causal direction can be established.